AstraZeneca Expects Gov’t-Paid Portion Of Rx Sales To Double Under Medicare
AstraZeneca anticipates that the proportion of its products paid for by the government will more than double when the Medicare Modernization Act takes effect in January
AstraZeneca anticipates that the proportion of its products paid for by the government will more than double when the Medicare Modernization Act takes effect in January